- Home
- DBI vs SXTC Comparison
DBI vs SXTC Comparison
Compare DBI & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBI
- SXTC
- Stock Information
- Founded
- DBI 1991
- SXTC 2005
- Country
- DBI United States
- SXTC China
- Employees
- DBI N/A
- SXTC N/A
- Industry
- DBI Clothing/Shoe/Accessory Stores
- SXTC Biotechnology: Pharmaceutical Preparations
- Sector
- DBI Consumer Discretionary
- SXTC Health Care
- Exchange
- DBI Nasdaq
- SXTC Nasdaq
- Market Cap
- DBI 138.7M
- SXTC 164.8M
- IPO Year
- DBI 1991
- SXTC 2019
- Fundamental
- Price
- DBI $4.26
- SXTC $1.66
- Analyst Decision
- DBI Hold
- SXTC
- Analyst Count
- DBI 2
- SXTC 0
- Target Price
- DBI $4.00
- SXTC N/A
- AVG Volume (30 Days)
- DBI 999.4K
- SXTC 490.3K
- Earning Date
- DBI 09-09-2025
- SXTC 01-01-0001
- Dividend Yield
- DBI 4.23%
- SXTC N/A
- EPS Growth
- DBI N/A
- SXTC N/A
- EPS
- DBI N/A
- SXTC N/A
- Revenue
- DBI $2,949,575,000.00
- SXTC $1,740,907.00
- Revenue This Year
- DBI N/A
- SXTC N/A
- Revenue Next Year
- DBI $2.45
- SXTC N/A
- P/E Ratio
- DBI N/A
- SXTC N/A
- Revenue Growth
- DBI N/A
- SXTC N/A
- 52 Week Low
- DBI $2.18
- SXTC $0.95
- 52 Week High
- DBI $7.46
- SXTC $7.84
- Technical
- Relative Strength Index (RSI)
- DBI 65.96
- SXTC 56.09
- Support Level
- DBI $3.65
- SXTC $1.13
- Resistance Level
- DBI $4.80
- SXTC $1.59
- Average True Range (ATR)
- DBI 0.27
- SXTC 0.12
- MACD
- DBI 0.10
- SXTC 0.01
- Stochastic Oscillator
- DBI 71.83
- SXTC 93.52
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.